Screening novel drugs against human pathogens Jun 10, 2024 - Aug 19, 2024
Projects (12)
Evaluation of a digital Solution for the Assessment and Management of Pain in Scottish Care Services Jul 31, 2024 - Apr 24, 2025
This project focuses on evaluating a digital solution for assessing and managing pain among individuals with moderate to severe dementia in Scottish Care Services. The evaluation will focus on whether the tool contributed to improved patient outcomes...
Read More about Evaluation of a digital Solution for the Assessment and Management of Pain in Scottish Care Services.
Animal Health as a Climate Solution: Phase I Oct 1, 2024 - Sep 30, 2025
EDF requests a 12-month grant of $946,022 to support scoping and coordination to set the stage for global action on animal health as a climate solution. This Phase I effort will begin to develop a robust body of evidence demonstrating the relationshi...
Read More about Animal Health as a Climate Solution: Phase I.
British Council - TNE Exploratory Grant - with ACU Jan 1, 2025 - Dec 31, 2025
Co-development of a Professional Diploma in Pharmaceutical Science - a first step to a long-term educational partnership between Edinburgh Napier University (UK) and Ahram Canadian University (Egypt)
Algumer Enzyme Protection Dec 2, 2024 - Apr 30, 2025
Solid detergents, such as laundry sheets represent an excellent way to reduce water, waste, storage and transport costs, and packaging. However the manufacturing process of the sheet involves exposure to elevated temperatures to remove the water. Thi...
Read More about Algumer Enzyme Protection.
Sustainable wild seaweed Jan 1, 2025 - Jun 30, 2025
Investigating the options for the use of seaweed as an alternative source for nanocellulose production for the medical industry.
Fleming Fund mentorship Feb 1, 2025 - Jan 31, 2026
Mentorship of Fleming fund fellows from Malawi and Kenya
Fleming Fund mentorship Feb 1, 2025 - Jan 31, 2026
Fleming Fund mentorship
Development of new sustainable approach in drug discovery: One-pot parallel synthetic strategy to minimise the environmental footprint May 1, 2024 - Apr 30, 2025
Over thousands of Medicinal Chemistry research groups around the world across academia, research-based institutions are involved in synthesizing libraries of compounds in the early drug discovery phase. During this synthetic process, massive amount o...
Read More about Development of new sustainable approach in drug discovery: One-pot parallel synthetic strategy to minimise the environmental footprint.
The prevalence, sources and diversity of antibiotic resistant E. coli in Scottish surface waters: a baseline for risk assessment and intervention targets. Oct 1, 2022 - Sep 30, 2026
The alarming rise in resistance to antibiotics is now widely accepted as being one of the most serious public health crises we face today. The use and overuse of antibiotics in human and animal medicine and especially the overuse in animal food produ...
Read More about The prevalence, sources and diversity of antibiotic resistant E. coli in Scottish surface waters: a baseline for risk assessment and intervention targets..
Development of an in vitro suppression assay to assess functionality of therapeutic regulatory T cell for the treatment of rheumatoid arthritis Jun 11, 2023 - Aug 14, 2024
MRS Summer Studentship for ENU Undergrad student Martin Swapp - 8 weeks in duration over summer 2023
Development of an immobilized artificial membrane liquid chromatography /mass spectrometry-based platform to assess the pulmonary permeability of drug candidates. Jun 12, 2023 - Aug 4, 2023
In this project, 53 analytes whose apparent permeability through Calu-3 cell line is known from the literature (Lin, Chiu, Wang, & Tung, 2022) will be studied by immobilized artificial membrane (IAM)- HPLC. Indeed, Berry and co-workers (Zemski Berry...
Read More about Development of an immobilized artificial membrane liquid chromatography /mass spectrometry-based platform to assess the pulmonary permeability of drug candidates..